Table 1.
Cost category | Current scheme | Alternative scheme | % Difference |
---|---|---|---|
Logistical costs | 5.80 | 2.33 | –59.8% |
Vaccination costs | 60.86 | 98.66 | + 62.1% |
Cost of treatment for adverse reactions | 11,293.89 | 28.22 | –99.8% |
Cost of treatment of common adverse reactions | 37.75 | 28.22 | –25.3% |
Cost of treatment of OPV-derived polio | 11,256.14 | – | –100.0% |
Social cost of lost time | 1,289.65 | 17.50 | –98.6% |
Cost of time lost due to vaccination | 9.31 | 8.22 | –11.7% |
Cost of time lost due to treatment of common adverse reactions | 12.37 | 9.28 | –25.0% |
Cost of time lost due to OPV-derived polio | 1,267.97 | – | –100.0% |
Total | 116.27 | 126.42 | + 8.7% |
USD, $1 equal to S/ 3.374 Peruvian Soles (average accounting exchange rate reported on December 31, 2018 by the Peruvian Superintendence of Banks, Insurance and Private Pension Fund Administrators [Superintendencia de Banca, Seguros y AFP]) [36]. OPV, oral polio vaccine; USD, US dollar